Support the news

A Look At Billion-Dollar Deals For ChemChina And Pfizer03:47
Download

Play
Chairman of Swiss farm chemicals giant Syngenta, Michel Demare shakes hands with Chairman of ChemChina Ren Jianxin during a press conference on Feb. 3, 2016. (Michael Buholzer/AFP/Getty Images)
Chairman of Swiss farm chemicals giant Syngenta, Michel Demare shakes hands with Chairman of ChemChina Ren Jianxin during a press conference on Feb. 3, 2016. (Michael Buholzer/AFP/Getty Images)
This article is more than 4 years old.

The United States government has signed off on ChemChina's $43 billion acquisition of Syngenta, one of the world's biggest agricultural chemical and seed producers. When the deal is finalized, it will be China's biggest-ever foreign acquisition.

Another major acquisition is also in the works, with Pfizer agreeing to buy the biotech company Medivation — which makes a leading cancer drug — for $14 billion.

Here & Now's Meghna Chakrabarti speaks with Jill Schlesinger of CBS News about the acquisitions.

Guest

Jill Schlesinger, CBS News business analyst and host of "Jill on Money." She tweets @jillonmoney.

This segment aired on August 22, 2016.

Related:

Support the news

Support the news